The West Point Senior Care Study UPDATE 18 MAY 11

Size: px
Start display at page:

Download "The West Point Senior Care Study UPDATE 18 MAY 11"

Transcription

1 The West Point Senior Care Study UPDATE 18 MAY 11

2 Introduction Paula A Corrigan, MD MPH Col USAF MC CFS Program Director General Preventive Medicine Residency USAFSAM, Brooks City-Base TX Principle Investigator West Point Senior Care Study Toni Randall, BA Psychology Executive Assistant West Point Senior Care Study

3 Presentation Overview West Point Study Background West Point Senior Care Study Background Alzheimer s/dementia Background Proposal for Alzheimer s/dementia Data Collection

4 The West Point Study Initiated to investigate whether the military can identify those who are at high risk of cardiovascular disease (CVD) by looking at risk factors BP, Cholesterol, Exercise, Smoking Funding came through in 1952 and USMA Class of 1956 selected to participate in the study Cohort of 474 upon graduation in members of the cohort (81%) underwent a final detailed cardiac evaluation at Brooks in 1992

5 Results 46 had been identified as having CVD by that time: 5 sudden cardiac deaths 14 heart attacks 12 angina 15 asymptomatic but identified on studies 12% incidence of CVD (less than US population at same age 17%) Risk of CVD did relate to risk factors, with smoking and cholesterol having the highest correlation

6 West Point Senior Care Study The goals of the original study had been met and the study was stopped in 1992 The West Point Senior Care Study was initiated in 2001 New cohort added spouses to the mix 306 of the original WPS cohort (65%) 170 additional spouses New data collection Health surveys every two years All voluntary Determine activity and functionality of cohort as they age

7 West Point Senior Care Study Surveys sent 2002, 2004, 2006, 2008 Data organized and analyzed No significant trends identified Nothing worthy of publishing so far Strengths of study: Great support from cohort with average 77% participation rate for questionnaires

8 West Point Senior Care Study Future direction Class members voiced interest in participating in Alzheimer s research Literature search begun to identify if there was a way to collect meaningful data from the group about Alzheimer s and dementia Proposal drafted concerning adding this to ongoing study

9 Alzheimer s Disease and Dementia Dementia is caused by various diseases that result in damaged brain cells and their connections Alzheimer s disease Vascular dementia Dementia with Lewy bodies Parkinson s disease Frontotemporal dementia CJD Normal pressure hydrocephalus Mixed dementia Dementia causes memory loss and other decline in cognitive function

10 Alzheimer s Statistics An estimated 5.4 million Americans have AD 13% of Americans over age 65 have AD (5.2 million) Nearly 50% of those over age 85 have AD 2/3 of those with AD are women Women live longer than men so are more likely to develop AD or dementia in their lifetime At any given age, women are not more likely than men to develop AD With the aging population, by 2030 those over age 65 with AD is estimated to increase by 50% to 7.7 million AD is the 6 th leading cause of death, and the 5 th leading cause for those age 65 or older

11 Risk Factors for Alzheimer s and Dementia Advancing age (over age 65) Family history Educational level Vascular disease Head trauma Cardiovascular risk factors Some studies have correlated mid-life chol levels with risk Apolipoprotein E (APOE)- e4 gene Provides blueprint for protein that carries cholesterol in bloodstream Those with one or two APOE-e4 genes are at higher risk to develop Alzheimer s Mild cognitive impairment

12 Mild Cognitive Impairment Mild cognitive impairment (MCI) as determined on screening tests Some individuals with MCI will develop dementia, some will not Of those with MCI, up to 15% per year will progress to dementia One tool for screening for MCI is the AD8 questionnaire developed by Washington Univ. Alzheimer s Disease Research Center 8 questions, scored by spouse or other informant Can determine who have further assessment for dementia

13 Preventing Alzheimer s and Dementia New research focused on going back in time to determine when and how the brain deteriorates Current treatment not very effective at treating the disease as the brain is already damaged If we can determine risk factors, particularly those that are modifiable, it could help us to slow down the disease West Point Class of 1956 has a wealth of data concerning modifiable risk factors collected over many years, especially cholesterol, which has been linked to AD Proposal is to now collect more dementia related information as part of the Senior Care Study, including MCI screen, and try to correlate to earlier data

14 New Proposal Send out usual surveys Fall 2011 Add the AD8 questionnaire to be answered by a spouse or family member of Class of 1956 members Obtain current cholesterol data, if possible Follow data on which Class members develop Alzheimer s or dementia and correlate with MCI and cholesterol data to see if connection exists If class agrees, new protocol must be approved by 711 HPW Institutional Review Board (IRB) this summer

15 West Point Senior Care Study Administration USAFSAM has moved from Brooks City-Base to Wright Patterson AFB Study continues to be funded and located at WPAFB Col Kelly West new Principle Investigator (PI) Ms Toni Randall to continue as Assistant Records have moved to WPAFB Hard copy and electronic data are always maintained in a secure manner and no personal information is seen by other than PI and assistant

16 Conclusion The West Point Study represents one of the longest running studies on cardiac risk factors in the USA We are grateful to the class of 1956 for their dedication and support of this effort We hope to be able to collect meaningful data related to the risk of Alzheimer s and dementia with the goal of publication in a scientific journal

17 Questions?

ALZHEIMER S DISEASE OVERVIEW. Jeffrey Cummings, MD, ScD Cleveland Clinic Lou Ruvo Center for Brain Health

ALZHEIMER S DISEASE OVERVIEW. Jeffrey Cummings, MD, ScD Cleveland Clinic Lou Ruvo Center for Brain Health ALZHEIMER S DISEASE OVERVIEW Jeffrey Cummings, MD, ScD Cleveland Clinic Lou Ruvo Center for Brain Health Prevalence AD: DEMOGRAPHY AND CLINICAL FEATURES Risk and protective factors Clinical features and

More information

Research ALZHEIMER S DISEASE AND RISK FACTORS

Research ALZHEIMER S DISEASE AND RISK FACTORS Research ALZHEIMER S DISEASE AND RISK FACTORS What is Alzheimer s disease? Alzheimer s disease is the most common of a large group of disorders known as dementias. It is an irreversible disease of the

More information

Living Better Series Normal Aging vs Dementia What is Brain Health?

Living Better Series Normal Aging vs Dementia What is Brain Health? Living Better Series Normal Aging vs Dementia What is Brain Health? 2018 What is Brain Health Brain health refers to the ability to remember, learn, plan, concentrate and maintain a clear, active mind.

More information

Contents. Introduction. Introduction 03

Contents. Introduction. Introduction 03 Genes and dementia Introduction This information is for anyone who wants to know more about the link between genes and dementia. This includes people living with dementia, their carers, friends and families.

More information

Senior Moments or Something More? Copyright James L. West Alzheimer s Center, 2013 All Rights Reserved

Senior Moments or Something More? Copyright James L. West Alzheimer s Center, 2013 All Rights Reserved Senior Moments or Something More? Copyright James L. West Alzheimer s Center, 2013 All Rights Reserved Defining Dementia Dementia is a group of symptoms affecting intellectual and social abilities severely

More information

Talib Y. Ali, MD, MPH Lt Col, USAF, MC, FS. USAF School of Aerospace Medicine WPAFB, OH RAM 2013

Talib Y. Ali, MD, MPH Lt Col, USAF, MC, FS. USAF School of Aerospace Medicine WPAFB, OH RAM 2013 Association of New Left Anterior Fascicular Block with Structural Heart Disease in U.S. Air Force Military Aircrew Talib Y. Ali, MD, MPH Lt Col, USAF, MC, FS USAF School of Aerospace Medicine WPAFB, OH

More information

What is dementia? What is dementia?

What is dementia? What is dementia? What is dementia? What is dementia? What is dementia? Dementia is an umbrella term for a range of progressive conditions that affect the brain. There are over 200 subtypes of dementia, but the five most

More information

Smoking stops declining and shows signs of increasing among younger teens

Smoking stops declining and shows signs of increasing among younger teens Dec. 14, 21 Contacts: Laura Lessnau, (734) 647-1851, llessnau@umich.edu Patti Meyer, (734) 647-183, mtfinfo@isr.umich.edu Study Web site: www.monitoringthefuture.org EMBARGOED FOR RELEASE AFTER 1 A.M.

More information

Considering depression as a risk marker for incident coronary disease

Considering depression as a risk marker for incident coronary disease Considering depression as a risk marker for incident coronary disease Dr Adrienne O'Neil Senior Research Fellow Melbourne School of Population & Global Health The University of Melbourne & Visiting Fellow

More information

What is dementia? What is dementia?

What is dementia? What is dementia? What is dementia? What is dementia? What is dementia? Dementia is an umbrella term for a range of progressive conditions that affect the brain. It has been identified that there are over 200 subtypes of

More information

Neurological Alliance of Ireland Pre-Budget Submission 2018

Neurological Alliance of Ireland Pre-Budget Submission 2018 Neurological Alliance of Ireland Pre-Budget Submission 2018 1 The Neurological Alliance of Ireland (NAI) is asking the Government to support people with neurological conditions in Ireland in the Budget

More information

Dementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology

Dementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology Dementia Stephen S. Flitman, MD Medical Director 21st Century Neurology www.neurozone.org Dementia is a syndrome Progressive memory loss, plus Progressive loss of one or more cognitive functions: Language

More information

Cognitive Screening in Risk Assessment. Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University.

Cognitive Screening in Risk Assessment. Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University. Cognitive Screening in Risk Assessment Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University Outline of Talk Definition of Dementia and MCI Incidence and Prevalence

More information

FROM THE ALZHEIMER S ASSOCIATION INTERNATIONAL CONFERENCE 2018

FROM THE ALZHEIMER S ASSOCIATION INTERNATIONAL CONFERENCE 2018 FOR IMMEDIATE RELEASE CONTACT: Alzheimer s Association AAIC Press Office, 312-949-8710, aaicmedia@alz.org Niles Frantz, Alzheimer s Association, 312-335-5777, nfrantz@alz.org FROM THE ALZHEIMER S ASSOCIATION

More information

Learning Outcomes. To have a clear understanding of the term dementia, and current facts and statistics relating to dementia.

Learning Outcomes. To have a clear understanding of the term dementia, and current facts and statistics relating to dementia. Learning Outcomes To have a clear understanding of the term dementia, and current facts and statistics relating to dementia. To be familiar with some of the common types of dementia. To understand what

More information

Dementia NICE Guidelines Update. Key points for primary care - NICE guideline (June 2018 update ) 26 September 2018

Dementia NICE Guidelines Update. Key points for primary care - NICE guideline (June 2018 update ) 26 September 2018 Dementia NICE Guidelines Update Key points for primary care - NICE guideline (June 2018 update ) 26 September 2018 How NICE guidelines are reviewed Multidisciplinary guideline committee established Review

More information

Clinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV)

Clinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV) Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV) A. The development of multiple cognitive deficits manifested by both 1 and 2 1 1. Memory impairment 2. One (or more) of the following

More information

Cardiovascular Disease in Tennessee. Audrey M Bauer, DVM, MPH Surveillance, Epidemiology and Evaluation Tennessee Department of Health

Cardiovascular Disease in Tennessee. Audrey M Bauer, DVM, MPH Surveillance, Epidemiology and Evaluation Tennessee Department of Health Cardiovascular Disease in Tennessee Audrey M Bauer, DVM, MPH Surveillance, Epidemiology and Evaluation Tennessee Department of Health Practical Strategies in Medication Adherence for Cardiac and Stroke

More information

Dementia. Jeanette Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine

Dementia. Jeanette Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine Dementia Jeanette Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine What is Dementia? Dementia is a general term referring to a decline in cognitive/mental functioning; this decline

More information

COMMUNITY EFFORTS TO PREVENT TYPE 2 DIABETES

COMMUNITY EFFORTS TO PREVENT TYPE 2 DIABETES COMMUNITY EFFORTS TO PREVENT TYPE 2 DIABETES 15 th Population Health Colloquium March 23, 2015 Marti Macchi, MEd., MPH Senior Consultant National Association of Chronic Disease Directors Today s Agenda

More information

BGS Spring Risk Factors and Preventative Strategies for Dementia

BGS Spring Risk Factors and Preventative Strategies for Dementia Risk Factors and Preventative Strategies for Dementia Dr Blossom Stephan Senior Lecturer (in Risk Prediction) Newcastle University Institute for Ageing and Institute of Health and Society BGS Spring Meeting

More information

LEARNING OBJECTIVES BACKGROUND WHO S BEHIND THE FOUNTAIN OF HEALTH? FOH NATIONAL LEADERSHIP TEAM. What is FoH? How Was It Developed? Who Is Involved?

LEARNING OBJECTIVES BACKGROUND WHO S BEHIND THE FOUNTAIN OF HEALTH? FOH NATIONAL LEADERSHIP TEAM. What is FoH? How Was It Developed? Who Is Involved? LEARNING OBJECTIVES At the end of this presentation you will be able to Explain what the Fountain of Health (FoH) Initiative is State why health behaviour change matters HEALTH & RESILIENCE PROMOTION INVITING

More information

Every 67seconds, someone will develop Alzheimer's.

Every 67seconds, someone will develop Alzheimer's. We all need a purpose and responsibilities to live a healthy life. Dementia Care 101 Corrin Campbell BS, COTA/L & Michael Urban, MS, OTR/L, MBA Every 67seconds, someone will develop Alzheimer's. http://www.alz.org

More information

Alzheimer s Disease. Fact Sheet. Fact Sheet. Fact Sheet. What Causes AD?

Alzheimer s Disease. Fact Sheet. Fact Sheet. Fact Sheet. What Causes AD? 2 Alzheimer s Disease Dementia is a brain disorder that seriously affects a person s ability to carry out daily activities. The most common form of dementia among older people is Alzheimer s disease (AD),

More information

Dementia Care in Barbados

Dementia Care in Barbados Dementia Care in Barbados REGIONAL CARIBBEAN CONFERENCE ALZHEIMER S AND DEMENTIA LLOYD ERSKINE SANDIFORD CENTRE DR. AMBROSE RAMSAY FEBRUARY 26 2016 Objectives Barbados demographic data Dementia data Formal

More information

Dementia Friends Workshop

Dementia Friends Workshop Dementia Friends Workshop Alzheimer Society of B.C. @AlzheimerBC #dementiafriendly 1 Alzheimer Society of B.C. Help for Today. Hope for Tomorrow 2 First Link Your link to dementia support ensures people

More information

The South Carolina Alzheimer's Disease Registry: A Unique Asset for Statewide Surveillance and Research

The South Carolina Alzheimer's Disease Registry: A Unique Asset for Statewide Surveillance and Research The South Carolina Alzheimer's Disease Registry: A Unique Asset for Statewide Surveillance and Research Presenters Lee Pearson MS, DrPH Co-director Maggi Miller MS, PhD Registry Manager Acknowledgements

More information

Alzheimer s & Related Dementias Support & Resources for SASH. June 13, 2018

Alzheimer s & Related Dementias Support & Resources for SASH. June 13, 2018 Alzheimer s & Related Dementias Support & Resources for SASH June 13, 2018 1 Today s Agenda Overview of Alzheimer's as a public health issue- why this matters! The Alzheimer s Association- who we are and

More information

Meaningful Engagement of People with Dementia

Meaningful Engagement of People with Dementia Meaningful Engagement of People with Dementia Mary E. Schulz Director, Information, Support Services and Education Alzheimer Society of Canada Alzheimer s Disease International Conference 21-24, April

More information

Movement and Memory. Undergraduate degree. Technology & Movement: New Approaches to Understanding Change. Graduate degree

Movement and Memory. Undergraduate degree. Technology & Movement: New Approaches to Understanding Change. Graduate degree Tracy Zitzelberger, MPH Technology & Movement: New Approaches to Understanding Change Tracy Zitzelberger, MPH Administra9ve Director Layton Aging & Alzheimer's Disease Center Oregon Center for Aging &

More information

The Importance of Full and Informed Consent (Authorisation)

The Importance of Full and Informed Consent (Authorisation) The Importance of Full and Informed Consent (Authorisation) 20 th November 2009 Tracey Millar University of Edinburgh Tracey.Millar@ed.ac.uk www.edinburghbrainbanks.ed.ac.uk Why are Brains needed for Research?

More information

Scams: Influencing the Aging Brain

Scams: Influencing the Aging Brain Neuropsychology: study of the brain and how it relates to cognition, emotion, and behavior Neuropsychological Assessment: a comprehensive evaluation of how the brain is functioning. Examines cognitive

More information

Current Issues and Initiatives in Alzheimer s Research and Services. Disclosure. I have no relevant financial relationships to disclose

Current Issues and Initiatives in Alzheimer s Research and Services. Disclosure. I have no relevant financial relationships to disclose Current Issues and Initiatives in Alzheimer s Research and Services Carroll Rodriguez VP Public Policy and Communications Alzheimer s Association St. Louis Chapter 1 Disclosure I have no relevant financial

More information

Corporate Medical Policy Genetic Testing for Alzheimer s Disease

Corporate Medical Policy Genetic Testing for Alzheimer s Disease Corporate Medical Policy Genetic Testing for Alzheimer s Disease File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_alzheimers_disease 8/2010 10/2017 10/2018 10/2017

More information

The Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing an example of Australian research on Alzheimer s disease

The Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing an example of Australian research on Alzheimer s disease The Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing an example of Australian research on Alzheimer s disease AIBL: Two site collaborative study Study is conducted at two sites: Perth

More information

What is dementia? Symptoms of dementia. Memory problems

What is dementia? Symptoms of dementia. Memory problems What is dementia? What is dementia? What is dementia? Dementia is an umbrella term for a range of progressive conditions that affect the brain. The brain is made up of nerve cells (neurones) that communicate

More information

1 in 3 seniors dies with Alzheimer s or another dementia.

1 in 3 seniors dies with Alzheimer s or another dementia. 2013 Alzheimer s disease facts and figures Includes a Special Report on long-distance caregivers 1 in 3 seniors dies with Alzheimer s or another dementia. Out-of-pocket expenses for long-distance caregivers

More information

RISK FACTORS FOR DEMENTIA

RISK FACTORS FOR DEMENTIA RISK FACTORS FOR DEMENTIA What are risk factors? For some diseases a definite cause is known. This is especially true for infections like measles, malaria or flu. However the situation is more complicated

More information

Dementia Care Pathway

Dementia Care Pathway Document level: West Locality Code: CC41 Issue number: 1 Dementia Care Pathway Lead executive Authors details Type of document Target audience Document purpose Medical Director Dr Anushta Sivananthan Dr

More information

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland AWARD NUMBER: W81XWH-13-1-0479 TITLE: Sleep-Disordered Breathing in Chronic SCI: A Randomized Controlled Trial of Treatment Impact on Cognition, Quality of Life, and Cardiovascular Disease PRINCIPAL INVESTIGATOR:

More information

Evaluations & CE Credits

Evaluations & CE Credits Evaluations & CE Credits Nursing Contact Hours, CME, CHES and Social Work credits are available. Please visit www.phlive.org to fill out your evaluation and complete the post-test. 1 Clinical and Ethical

More information

PALS NEWSLETTER. February A newsletter of the Pittsburgh ADHD Longitudinal Study STUDY UPDATE PARKING IN OAKLAND

PALS NEWSLETTER. February A newsletter of the Pittsburgh ADHD Longitudinal Study STUDY UPDATE PARKING IN OAKLAND PALS NEWSLETTER A newsletter of the Pittsburgh ADHD Longitudinal Study STUDY UPDATE As you may remember, we formally changed the way that we refer to the study to the PALS Study for the Pittsburgh ADHD

More information

9/8/2017. Dementia Symptoms. Judi Kelly Cleary, CDP, ALFA Executive Director, Branchlands

9/8/2017. Dementia Symptoms. Judi Kelly Cleary, CDP, ALFA Executive Director, Branchlands Judi Kelly Cleary, CDP, ALFA Executive Director, Branchlands What Dementia is, and the types of Dementia The stages of an Alzheimer s Disease Type of Dementia Effective Support Strategies at the Various

More information

MEMORY ASSESSMENT AND RESEARCH CENTRE (MARC) RESULTS OF THE 2012 MARC FEEDBACK QUESTIONNAIRE AUDIT

MEMORY ASSESSMENT AND RESEARCH CENTRE (MARC) RESULTS OF THE 2012 MARC FEEDBACK QUESTIONNAIRE AUDIT N.B. This project was first delivered in 2012 by the then Dementias and Neurodegenerative Diseases Research Network (DeNDRoN). MEMORY ASSESSMENT AND RESEARCH CENTRE (MARC) RESULTS OF THE 2012 MARC FEEDBACK

More information

Dementia in Independent Senior Housing: Concerns, Barriers and Solutions

Dementia in Independent Senior Housing: Concerns, Barriers and Solutions Dementia in Independent Senior Housing: Concerns, Barriers and Solutions LeadingAge NY April 13, 2016 Kelly Papa, MSN, RN Masonicare Corporate Director of Learning The Big Question How can we create systems

More information

Getting to Know the Generation Program s Approach to Disclosing Information about Your Risk for Alzheimer s disease

Getting to Know the Generation Program s Approach to Disclosing Information about Your Risk for Alzheimer s disease Getting to Know the Generation Program s Approach to Disclosing Information about Your Risk for Alzheimer s disease The Generation Program is made up of two clinical trials: Generation Study 1 and Generation

More information

Understanding Dementia

Understanding Dementia Dementia Handbook for Carers Essex Understanding Dementia What is dementia? 1 Summary of dementia symptoms 4 Medication and treatment 5 1 Dementia is the name for several conditions that lead to the progressive

More information

Community Health Needs Assessmen. Implementation Strategy

Community Health Needs Assessmen. Implementation Strategy Community Health Needs Assessmen Implementation Strategy HOSPITAL BACKGROUND Baptist Memorial Restorative Care Hospital was established in 1994 as a long term acute care hospital and is located within

More information

Background. In discussions of recruitment, the question was raised as to whether returning research results to subjects would help recruitment.

Background. In discussions of recruitment, the question was raised as to whether returning research results to subjects would help recruitment. Alzheimer s Disease Neuroimaging Initiative Return of Research Results Working Group The REVEAL Study NHGRI/NIA Funded d 2000-2013 2013 Background In discussions of recruitment, the question was raised

More information

When the Diagnosis Is Dementia- What You Can Do? Howard Gruetzner, M.Ed., LPC Educational and Family Care Specialist North Central Texas Chapter

When the Diagnosis Is Dementia- What You Can Do? Howard Gruetzner, M.Ed., LPC Educational and Family Care Specialist North Central Texas Chapter When the Diagnosis Is Dementia- What You Can Do? Howard Gruetzner, M.Ed., LPC Educational and Family Care Specialist North Central Texas Chapter Visibility of Disease Only 19 percent of people with Alzheimer

More information

Ontario Seniors Health Strategy: Implications for Geriatric Day Hospitals

Ontario Seniors Health Strategy: Implications for Geriatric Day Hospitals Ontario Seniors Health Strategy: Implications for Geriatric Day Hospitals Presentation to the Regional Geriatric Day Hospital Forum November 28, 2014 Objective Provide overview of provincial and regional

More information

Alzheimer s Disease and Related Disorders: The Public Health Call to Action

Alzheimer s Disease and Related Disorders: The Public Health Call to Action Levine Alzheimer s Disease and Related Disorders: The Public Health Call to Action Jed A. Levine, M.A. Executive Vice President Director of Programs and Services Alzheimer s Association, New York City

More information

Understanding Dementia

Understanding Dementia Understanding Dementia Dr. Dallas Seitz MD FRCPC Assistant Professor, Department of Psychiatry, Queen s University, Kingston, Ontario, Canada What s Next Information about Dementia, Elder Care and Supports

More information

East End Neuropsychiatric Associates 2539 Middle Country Rd Suite 4 Centereach, NY (631) What is Vascular Dementia?

East End Neuropsychiatric Associates 2539 Middle Country Rd Suite 4 Centereach, NY (631) What is Vascular Dementia? Dementia is diagnosed when both memory and another cognitive function are each affected severely enough to interfere with a person's ability to carry out routine daily activities. The Journal of the American

More information

A Unique Partnership to Advance Alzheimer's Research through Whole Genome Sequencing.

A Unique Partnership to Advance Alzheimer's Research through Whole Genome Sequencing. A Unique Partnership to Advance Alzheimer's Research through Whole Genome Sequencing. Dean Hartley, Ph.D., Alzheimer's Association, Emily Drabant, Ph.D., 23 and me, Anne Wojcicki, 23 and me, Rob Fetherstonhaugh,

More information

Tuberculosis Among Health Care Workers, Researchers, Trainees, and Travelers to Kenya in Association with AMPATH

Tuberculosis Among Health Care Workers, Researchers, Trainees, and Travelers to Kenya in Association with AMPATH Tuberculosis Among Health Care Workers, Researchers, Trainees, and Travelers to Kenya in Association with AMPATH Adrian Gardner MD, MPH Clinical Research Fellow, Infectious Diseases Miriam Hospital/Alpert

More information

Molecular Imaging and the Brain

Molecular Imaging and the Brain Molecular imaging technologies are playing an important role in neuroimaging, a branch of medical imaging, by providing a window into the living brain. Where CT and conventional MR imaging provide important

More information

Appendix C CHANGING THE TRAJECTORY:

Appendix C CHANGING THE TRAJECTORY: Appendix C CHANGING THE TRAJECTORY: Impact of a Hypothetical Treatment That Slows the Progression of Alzheimer s In addition to the delayed onset scenario discussed in the report, another potential scenario

More information

Joint Dementia Strategy Improving the lives of people with dementia in Wolverhampton. Endorsed by Wolverhampton DAA

Joint Dementia Strategy Improving the lives of people with dementia in Wolverhampton. Endorsed by Wolverhampton DAA Joint Dementia Strategy 2015 17 Improving the lives of people with dementia in Wolverhampton Endorsed by Wolverhampton DAA Introduction Dementia is one of the biggest challenges facing the nation today.

More information

Dementia and the Memory Service. What is it? What do we do about it?

Dementia and the Memory Service. What is it? What do we do about it? Dementia and the Memory Service What is it? What do we do about it? Content Dementia Types Symptoms Effects and impact Memory Service What is Dementia? Dementia is an umbrella term used to describe the

More information

Alzheimer Disease and Related Dementias

Alzheimer Disease and Related Dementias Alzheimer Disease and Related Dementias Defining Generic Key Terms and Concepts Mild cognitive impairment: (MCI) is a state of progressive memory loss after the age of 50 that is beyond what would be expected

More information

Overview. Let s Talk: A Discussion About Dementia. Difference between normal aging and dementia. What is Alzheimer s disease? Recognize the symptoms

Overview. Let s Talk: A Discussion About Dementia. Difference between normal aging and dementia. What is Alzheimer s disease? Recognize the symptoms Let s Talk: A Discussion About Dementia St. Margaret s Bay Seniors Association March 20, 2014 Overview Difference between normal aging and dementia What is Alzheimer s disease? Recognize the symptoms Importance

More information

Predictors of Depression Among Midlife Women in South Korea. Ham, Ok-kyung; Im, Eun-Ok. Downloaded 8-Apr :24:06

Predictors of Depression Among Midlife Women in South Korea. Ham, Ok-kyung; Im, Eun-Ok. Downloaded 8-Apr :24:06 The Henderson Repository is a free resource of the Honor Society of Nursing, Sigma Theta Tau International. It is dedicated to the dissemination of nursing research, researchrelated, and evidence-based

More information

UCLA Alzheimer s and Dementia Care: Comprehensive, Coordinated, Patient-Centered

UCLA Alzheimer s and Dementia Care: Comprehensive, Coordinated, Patient-Centered UCLA Alzheimer s and Dementia Care: Comprehensive, Coordinated, Patient-Centered David Geffen School of Medicine at UCLA Director: David B. Reuben, MD Medical Director: Zaldy S. Tan, MD, MPH Lead Dementia

More information

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia DISCLOSURES NONE TO REPORT Freddi Segal Gidan, PA, PhD USC Keck School of Medicine Rancho/USC California Alzheimers Disease

More information

California Pacific Medical Center Research Institute:

California Pacific Medical Center Research Institute: Wake Forest University Health Sciences: Laura D. Baker, PhD Sally Shumaker, PhD Stephen Rapp, PhD Beverly Snively, PhD Daniel Beavers, PhD Kate Hayden, PhD Emily Gower, PhD Kaycee Sink, MD Bonnie Sachs,

More information

PLEASE FILL OUT & RETURN

PLEASE FILL OUT & RETURN PLEASE FILL OUT & RETURN MEDICATION THERAPY MANAGEMENT (MTM) PROGRAM CONSENT and AUTHORIZATION for RELEASE of INFORMATION I agree to participate in the Medication Therapy Management (MTM) Program. I will

More information

PD ExpertBriefing: Cognition and PD: What You ve Always Wanted to Know But Were Too Afraid to Ask. Presented By: Tuesday, March 22, 2011 at 1:00 PM ET

PD ExpertBriefing: Cognition and PD: What You ve Always Wanted to Know But Were Too Afraid to Ask. Presented By: Tuesday, March 22, 2011 at 1:00 PM ET PD ExpertBriefing: Cognition and PD: What You ve Always Wanted to Know But Were Too Afraid to Ask Presented By: Alexander I. Tröster, PhD, ABPP University of North Carolina, Chapel Hill, NC Tuesday, March

More information

Brain Health and Risk Factors for Dementia

Brain Health and Risk Factors for Dementia Welcome To Brain Health and Risk Factors for Dementia Presented by Kamal Masaki, MD Professor and Chair Department of Geriatric Medicine John A. Burns School of Medicine, UH Manoa April 4, 2018 10:00 11:00

More information

At COLAGE, the only national youth-driven movement of people with lesbian, gay,

At COLAGE, the only national youth-driven movement of people with lesbian, gay, Final Report Emily McGranachan COLAGE At COLAGE, the only national youth-driven movement of people with lesbian, gay, bisexual, transgender and/or queer parents, I had a fair amount of responsibility and

More information

WASHINGTON STATE PLAN TO ADDRESS ALZHEIMER S DISEASE AND OTHER DEMENTIAS

WASHINGTON STATE PLAN TO ADDRESS ALZHEIMER S DISEASE AND OTHER DEMENTIAS WASHINGTON STATE PLAN TO ADDRESS ALZHEIMER S DISEASE AND OTHER DEMENTIAS W4A/SCOA GATHERING BOB LE ROY, EXECUTIVE DIRECTOR ALZHEIMER S ASSOCIATION WASHINGTON STATE CHAPTER OCTOBER 10, 2018 DEMENTIA BY

More information

TITLE: The Prospective Army Coronary Calcium (PAAC) Study

TITLE: The Prospective Army Coronary Calcium (PAAC) Study AD Award Number: DAMD17-98-C-8048 TITLE: The Prospective Army Coronary Calcium (PAAC) Study PRINCIPAL INVESTIGATOR: Allen J. Taylor, LTC, MC CONTRACTING ORGANIZATION: Systems Assessment and Research, Incorporated

More information

Preventing Cognitive Decline and Dementia A Way Forward

Preventing Cognitive Decline and Dementia A Way Forward Preventing Cognitive Decline and Dementia A Way Forward Ronald C. Petersen, PhD, MD Mayo Clinic Rochester, MN USA for Committee on Preventing Cognitive Decline National Academies of Science, Engineering

More information

Carol Manning, PhD, ABPP-CN Director, Memory Disorders Clinic University of Virginia

Carol Manning, PhD, ABPP-CN Director, Memory Disorders Clinic University of Virginia Carol Manning, PhD, ABPP-CN Director, Memory Disorders Clinic University of Virginia Case Study Mr. S. is a 74 year old man who has smoked for 20 years. He is overweight, has high cholesterol and high

More information

The REACH Caregiver Intervention Program: From Clinical Trial to Community Implementation. HRJ Endowed Chair University of Michigan

The REACH Caregiver Intervention Program: From Clinical Trial to Community Implementation. HRJ Endowed Chair University of Michigan The REACH Caregiver Intervention Program: From Clinical Trial to Community Implementation Lou Burgio, Ph.D. HRJ Endowed Chair University of Michigan Background dementia (Facts and Figures, Alzheimer s

More information

3 COMMON PSYCHIATRIC DISORDERS IN OLDER ADULTS: NEW INSIGHTS

3 COMMON PSYCHIATRIC DISORDERS IN OLDER ADULTS: NEW INSIGHTS 3 COMMON PSYCHIATRIC DISORDERS IN OLDER ADULTS: NEW INSIGHTS PHOVOIR/SHUTTERSTOCK Mild cognitive impairment (MCI), dementia, and depression are common in elderly patients. Three new studies focus on the

More information

Dementia Facts and Resources Dementia Warning Signs Getting a Diagnosis Dementia Communication Tips Dementia Risk Reduction.

Dementia Facts and Resources Dementia Warning Signs Getting a Diagnosis Dementia Communication Tips Dementia Risk Reduction. Dementia Facts and Resources Dementia Warning Signs Getting a Diagnosis Dementia Communication Tips Dementia Risk Reduction Intermission Dementia Stages and Behaviors Caregiving and Self-Care Overview

More information

DEMENTIA IN CANADA, INCLUDING ALZHEIMER S DISEASE

DEMENTIA IN CANADA, INCLUDING ALZHEIMER S DISEASE DEMENTIA IN CANADA, INCLUDING ALZHEIMER S DISEASE HIGHLIGHTS FROM THE CANADIAN CHRONIC DISEASE SURVEILLANCE SYSTEM According to the World Health Organization, 47.5 million people live with dementia, including

More information

Title & Subtitle can knockout of image

Title & Subtitle can knockout of image Title & Subtitle can knockout of image LARGE OPENING IMAGE HERE 50 accc-cancer.org July August 2016 OI BY PATRICIA INAMA RODA, MSN, BS, RN, AND JAIME FRITCHMAN, BS A Community Comes Together to Help Patients

More information

Overview of Alzheimer s Disease

Overview of Alzheimer s Disease Overview of Alzheimer s Disease Today s Objectives Provide an overview of Alzheimer s disease and related dementias Where can individuals, families and professionals get help Services available What is

More information

Youth Smoking. An assessment of trends in youth smoking through Wisconsin Department of Health and Family Services. Percent.

Youth Smoking. An assessment of trends in youth smoking through Wisconsin Department of Health and Family Services. Percent. Youth Smoking in Wisconsin: An assessment of trends in youth smoking through 24 United Wisco 7 6 5 4 Females Males 8 7 6 3 2 1993 2 21 22 2 6 5 4 65 64 66 62 63 58 53 55 51 53 5 4 3 2 2 21 22 23 24 12

More information

Cognitive Impairment - Parkinson's Disease Foundation (PDF)

Cognitive Impairment - Parkinson's Disease Foundation (PDF) Page 1 of 8 Cognitive Impairment Another troublesome symptom of Parkinson s is mild cognitive impairment. Many people with Parkinson s are surprised to find that they feel distracted or disorganized, or

More information

BioArctic announces detailed results of the BAN2401 Phase 2b study in early Alzheimer s disease presented at AAIC 2018

BioArctic announces detailed results of the BAN2401 Phase 2b study in early Alzheimer s disease presented at AAIC 2018 Press release BioArctic announces detailed results of the BAN2401 Phase 2b study in early Alzheimer s disease presented at AAIC 2018 Stockholm, Sweden, July 25, 2018 BioArctic AB (publ) (Nasdaq Stockholm:

More information

DEBORAH MCKERN. Aged Care Consultant

DEBORAH MCKERN. Aged Care Consultant DEBORAH MCKERN Aged Care Consultant CARING FOR DEMENTIA THE BOLD AND THE BEAUTIFUL Prevalence of Neurodegerative Disease In the > 75 year olds: Gait ataxia 50% Visual impairment 38% Cognitive impairment

More information

our vision our mission 7/24/18 Twin Ports Conference Session 202 Learning Objectives

our vision our mission 7/24/18 Twin Ports Conference Session 202 Learning Objectives Twin Ports Conference Session 202 Memory Loss and Dementia: An African American and Health Euity Lens Alzheimer s Association: Robbin Frazier, Director of Diversity and Inclusion E-mail: rfrazier@alz.org

More information

DCP Newsletter. Welcome. Issue 1 June Key Dates. National Men s Health Week June 2018

DCP Newsletter. Welcome. Issue 1 June Key Dates. National Men s Health Week June 2018 DCP Newsletter Issue 1 June 2018 Welcome Hello and a warm welcome to all of our readers of this first edition of the Dorset Cancer Partnership (DCP) newsletter. Each edition of this newsletter will provide

More information

annual report

annual report 2010-11 annual report A year in motion Annual Report From the director The past year has been one of substantial achievement for the Virginia Commonwealth University Parkinson s Disease Center. As a result

More information

Service Related Project. Kimberley Keegan

Service Related Project. Kimberley Keegan AN EVALUATION OF ADDENBROOKE S COGNITIVE EXAMINATION III (ACE-III) SCORES, NEUROPSYCHOLOGICAL ASSESSMENT SCORES, AND DIAGNOSIS OUTCOME WITHIN A MEMORY SERVICE. Service Related Project Kimberley Keegan

More information

The National Council for Palliative Care Awards 2017 Judges Profiles

The National Council for Palliative Care Awards 2017 Judges Profiles The National Council for Palliative Care Awards 2017 Judges Profiles Alison Penny Coordinator, Childhood Bereavement Network Alison coordinates the Childhood Bereavement Network (CBN) and provides project

More information

The Ethics of Working with Aging Donors

The Ethics of Working with Aging Donors The Ethics of Working with Aging Donors Tuesday, May 2, 2017 3:30pm Speakers Marla Beck Owner, Andelcare James R. Carney, CFP Morgan Stanley, Financial Advisor Janell Johnson Associate Director of Development:

More information

2010 Alzheimer s disease facts and figures

2010 Alzheimer s disease facts and figures Alzheimer s & Dementia 6 (2010) 158 194 Alzheimer s Association Report 2010 Alzheimer s disease facts and figures Alzheimer s Association* Abstract Keywords: Alzheimer s disease (AD) is the seventh leading

More information

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Dementia: the management of dementia, including the use of antipsychotic medication in older people

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Dementia: the management of dementia, including the use of antipsychotic medication in older people NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE 1 Guideline title SCOPE Dementia: the management of dementia, including the use of antipsychotic medication in older people 1.1 Short title Dementia 2 Background

More information

Please list medications and dosage (including non-prescriptions) you are currently taking or have taken recently:

Please list medications and dosage (including non-prescriptions) you are currently taking or have taken recently: Name: DOB: Today s Date: Primary Care Doctor: Referring Physician: What is the primary reason for today s visit? Medical History Please list medications and dosage (including non-prescriptions) you are

More information

UNITED STATES AIR FORCE AEROMEDICAL UPDATE AND REVIEW FOR AVIATORS WITH KNOWN CORONARY ARTERY DISEASE

UNITED STATES AIR FORCE AEROMEDICAL UPDATE AND REVIEW FOR AVIATORS WITH KNOWN CORONARY ARTERY DISEASE UNITED STATES AIR FORCE AEROMEDICAL UPDATE AND REVIEW FOR AVIATORS WITH KNOWN CORONARY ARTERY DISEASE Jason Dexter Cromar, M.D., M.P.H. Chief Resident, Aerospace & Occupational Medicine Capt, USAF, MC,

More information

TYPES & STAGES OF DEMENTIA AND WHAT IT MEANS FOR YOU. Dr John Mark Geiss Geiss MED, Senior Care Physicians June 28, 2017 Sponsored: ActivCare Living

TYPES & STAGES OF DEMENTIA AND WHAT IT MEANS FOR YOU. Dr John Mark Geiss Geiss MED, Senior Care Physicians June 28, 2017 Sponsored: ActivCare Living TYPES & STAGES OF DEMENTIA AND WHAT IT MEANS FOR YOU Dr John Mark Geiss Geiss MED, Senior Care Physicians June 28, 2017 Sponsored: ActivCare Living AN OVERVIEW OF ALZHEIMER S AND OTHER RELATED DEMENTIAS

More information

RURAL HEALTH AND ITS INFLUENCE ON THE GP PERSPECTIVE OF DEMENTIA

RURAL HEALTH AND ITS INFLUENCE ON THE GP PERSPECTIVE OF DEMENTIA RURAL HEALTH AND ITS INFLUENCE ON THE GP PERSPECTIVE OF DEMENTIA 14 TH NATIONAL RURAL HEALTH CONFERENCE APRIL 2017 ANGE CROMBIE, DIRECTOR RESEARCH & DEVELOPMENT Background Australia, like the rest of the

More information

Next patient please Dementia Clare Hawley 2018

Next patient please Dementia Clare Hawley 2018 Next patient please Dementia Clare Hawley 2018 I have no conflict of interest to declare Dr Clare Hawley Associate Specialist Cardiology Chesterfield Royal Hospital GPwSI Refractory Angina Hon Clinical

More information

DEMENTIA, THE BRAIN AND HOW IT WORKS AND WHY YOU MATTER

DEMENTIA, THE BRAIN AND HOW IT WORKS AND WHY YOU MATTER OVERCOMING THE CHALLENGES OF MANAGING CHRONIC DISEASES IN PERSONS WITH DEMENTIA DEMENTIA, THE BRAIN AND HOW IT WORKS AND WHY YOU MATTER LEARNING OBJECTIVES Be familiar with the diagnostic criteria for

More information

Learning Goals. Dementia Care Planning: It s A Family Affair. Participants will:

Learning Goals. Dementia Care Planning: It s A Family Affair. Participants will: Dementia Care Planning: It s A Family Affair MACIE P. SMITH, ED.D, LSW, C-SWCM, SW-G Learning Goals Participants will: Better understand the causes of dementia Gain a deeper understanding of dementia stages

More information

Evidence-Based Medicine for clinical years Sep 13 th 2016

Evidence-Based Medicine for clinical years Sep 13 th 2016 Evidence-Based Medicine for clinical years Sep 13 th 2016 Professor Carl Heneghan University of Oxford Director CEBM What is Evidence-Based Medicine? Evidence-based medicine is the integration of best

More information